Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 12SANOFI AVENTIS US
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2034-02-04
US Patent Number : 9186346
Drug Substance Claim :
Drug Product Claim :
Application Number : 202992
Patent Use Code : U-1786
Delist Requested :
Patent Use Description : TREATMENT OF PATIENTS ...
Patent Expiration Date : 2034-02-04
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2026-09-12
US Patent Number : 6794410
Drug Substance Claim :
Drug Product Claim :
Application Number : 202992
Patent Use Code : U-1285
Delist Requested :
Patent Use Description : TREATMENT OF PATIENTS ...
Patent Expiration Date : 2026-09-12
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2026-09-12
US Patent Number : 6794410
Drug Substance Claim :
Drug Product Claim :
Application Number : 202992
Patent Use Code : U-1285
Delist Requested :
Patent Use Description : TREATMENT OF PATIENTS ...
Patent Expiration Date : 2026-09-12
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2034-02-04
US Patent Number : 9186346
Drug Substance Claim :
Drug Product Claim :
Application Number : 202992
Patent Use Code : U-1786
Delist Requested :
Patent Use Description : TREATMENT OF PATIENTS ...
Patent Expiration Date : 2034-02-04
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2030-09-14
US Patent Number : 8802735
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202992
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-09-14
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2030-09-14
US Patent Number : 8802735
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 202992
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-09-14
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2031-03-14
US Patent Number : 8802735*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 202992
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-14
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2031-03-14
US Patent Number : 8802735*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 202992
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-14
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2027-03-12
US Patent Number : 6794410*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 202992
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-03-12
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2027-03-12
US Patent Number : 6794410*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 202992
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-03-12
